Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches
- 31 May 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cardiology
- Vol. 8 (9), 485-493
- https://doi.org/10.1038/nrcardio.2011.77
Abstract
Anemia and iron deficiency are common in patients with heart failure (HF), and are associated with worse symptoms and adverse outcomes in this population. Although the two can occur together, anemia in HF is often not caused by iron deficiency, and iron deficiency can be present without causing anemia. Erythropoiesis-stimulating agents have been investigated extensively in the past few years and might be of benefit in patients with HF and anemia. However, concerns have arisen regarding the safety of erythropoiesis-stimulating agents in patients with chronic kidney disease and so the results of a large mortality trial are eagerly awaited to provide information on safety in patients with HF. Iron supplementation or replacement is a much older treatment option for patients with HF and anemia, but questions about the safety of intravenous iron, and absorption problems with oral formulations have prevented its widespread use to date. In the past few years, however, new data on the importance of iron deficiency in HF have become available, and a number of studies with intravenous iron have shown promising results. Therefore, this treatment approach is likely to become an attractive option for patients with HF and iron deficiency, both with and without anemia.Keywords
This publication has 117 references indexed in Scilit:
- Erythropoietin Receptor Signaling Mitigates Renal Dysfunction-Associated Heart Failure by Mechanisms Unrelated to Relief of AnemiaJournal of the American College of Cardiology, 2010
- A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatmentKidney International, 2010
- Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR‐HF) study: a randomized, placebo‐controlled study of intravenous iron supplementation in patients with and without anaemiaEuropean Journal of Heart Failure, 2009
- Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2009
- Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in HemodialysisAmerican Journal of Kidney Diseases, 2008
- Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemiaAmerican Heart Journal, 2006
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseThe New England Journal of Medicine, 2006
- Intravenous Iron Alone for the Treatment of Anemia in Patients With Chronic Heart FailureJournal of the American College of Cardiology, 2006
- A precious metal: Iron, an essential nutrient for all cellsGenes & Nutrition, 2006
- Are hematinic deficiencies the cause of anemia in chronic heart failure?American Heart Journal, 2004